Bone Biologics

Bone Biologics Corporation is a Burlington, Massachusetts-based medical device company focused on bone regeneration in spinal fusion using its proprietary recombinant human NELL-1 protein (rhNELL-1), licensed from the UCLA Technology Development Group. Its lead product, the NELL-1/DBM device, is an osteopromotive recombinant protein combined with demineralized bone matrix for target-specific control of bone regeneration, with NB1 positioned for lumbar spinal fusion and additional applications in non-union trauma and osteoporosis. The company recently validated a 32-month shelf life for rhNELL-1 and continues development toward U.S. regulatory milestones.